Neuronetics
STIM
61 hedge funds and large institutions have $149M invested in Neuronetics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 9 closing their positions.
154% more capital invested
Capital invested by funds: $58.8M → $149M (+$90.5M)
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11% more funds holding
Funds holding: 55 → 61 (+6)
6.67% more ownership
Funds ownership: 64.17% → 70.84% (+6.7%)
43% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$5.67M |
| 2 |
FA
Friess Associates
Greenville,
Delaware
|
+$3.91M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.13M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
+$1.78M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$4.93M |
| 2 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$3.56M |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$2.04M |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$1.27M |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
-$1.1M |
STIM Hedge Fund Activity: Q4 2020 in Review
61 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q4 2020, worth a combined $149M — up 154% from $58.8M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new STIM positions and 9 closed out — a net gain of 6 holders — while 12 added to existing stakes and 21 trimmed.
The largest buyer was Royce & Associates, adding an estimated $5.67M. The largest seller was Deerfield Management, cutting an estimated $4.93M.
- 61 institutional investors held Neuronetics (STIM) as of Q4 2020, up from 55 in Q3 2020.
- Funds reported $149M of Neuronetics stock for Q4 2020, up 154% quarter-over-quarter.
- 15 funds opened new Neuronetics positions in Q4 2020 and 9 closed out, a net change of +6 holders.
- The largest Neuronetics buyer in Q4 2020 was Royce & Associates, an estimated $5.67M added.
- The largest Neuronetics seller in Q4 2020 was Deerfield Management, an estimated $4.93M sold.
Based on aggregated 13F filings for Q4 2020.